Efficacy and Safety of Tyrosine Kinase 2 Inhibitor Deucravacitinib in Psoriasis : A Systematic Review and Drug-Response Meta Analysis of RCTs. JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia, [S. l.], p. 10, 2025. DOI: 10.53366/jimki.vi.961. Disponível em: https://jimki.bapin.or.id/main/article/view/961. Acesso em: 25 jul. 2026.